Childhood vaccine finance and safety issues

Health Affairs

Volumn 23, Issue 5, 2004, Pages 98-111

  Giffin, Robert ^a   Stratton, Kathleen ^b   Chalk, Rosemary ^c  

^a INSTITUTE OF MEDICINE   (United States)

^b IOM Bd Hlth Prom and Dis Prev ^*

^c NATIONAL RESEARCH COUNCIL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES MUMPS VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PARAINFLUENZA VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RESPIRATORY SYNCTIAL VIRUS VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; STREPTOCOCCUS VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE; VIRUS VACCINE;

ANAPHYLAXIS; AUTISM; BRAIN DISEASE; CHRONIC ARTHRITIS; CRYING; DRUG COST; DRUG FATALITY; DRUG SAFETY; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GUILLAIN BARRE SYNDROME; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; HYPSARRYTHMIA; IMMUNIZATION; INFANTILE SPASM; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NEURITIS; NEUROLOGIC DISEASE; POLIOMYELITIS; REVIEW; REYE SYNDROME; SHOCK; SIDE EFFECT; SUDDEN INFANT DEATH SYNDROME; THROMBOCYTOPENIA; UNITED STATES; VIRUS INFECTION;

CHILD; CHILD WELFARE; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FINANCING, GOVERNMENT; HUMANS; IMMUNIZATION PROGRAMS; POLITICS; PUBLIC HEALTH PRACTICE; UNITED STATES;

EID: 4644224268     PISSN: 02782715     EISSN: None     Source Type: Journal    
DOI: 10.1377/hlthaff.23.5.98     Document Type: Review

References (31)

1. Four doses of diphtheria-tetanus-acellular pertussis (DTaP), three doses of polio, three doses of Haemophilus influenzae type b (Hib), and one dose of measles-mumps-rubella (MMR).
2. U.S. Centers for Disease Control and Prevention, "Summary of Notifiable Diseases, United States," Morbidity and Mortality Weekly Report 47, no. 53 (1998): 1-93.
3. CDC, "Ten Great Public Health Achievements - United States, 1900-1999," Morbidity and Mortality Weekly Report 48, no. 12 (1999): 241-264.
4. Institute of Medicine, Calling the Shots: Immunization Finance Policies and Practices (Washington: National Academies Press, 2000), ix.
5. M. Davis et al., "Childhood Vaccine Purchase Costs in the Public Sector: Past Trends, Future Expectations," American Journal of Public Health 92, no. 12 (2002): 1982-1986.
6. Hepatitis B, diphtheria, tetanus, pertussis, Hib, inactivated poliovirus, measles, mumps, rubella, varicella, pneumococcal, and influenza.
7. CDC, "Recommended Childhood and Adolescent Immunization Schedule - United States, July-December 2004," www.cdc.gov/nip/recs/child-schedule- jul-dec-rev.pdf (28 June 2004).
8. Figures are based on lowest available private-sector prices reported by the CDC, excluding excise taxes.
9. IOM, Financing Vaccines in the Twenty-first Century: Assuring Access and Availability (Washington: National Academies Press, 2004).
10. A recent CDC National Immunization Survey found that 79 percent of privately insured children had some sort of payment associated with their last immunization visit. Data from the 2002 National Immunization Survey, based on personal communication with Achal Bhatt, CDC, 17 December 2002.
11. Henry J. Kaiser Family Foundation and Health Research and Educational Trust, Employer Health Benefits: 2002 Annual Survey (Menlo Park, Calif.: Kaiser Family Foundation, 2002).
12. G. Freed et al., "Reimbursement for Prevnar: A Modern-Day Version of Hercules and the Hydra," Pediatrics 110, no. 2, Part 1 (2002): 99-400.
13. IOM, Calling the Shots, 9-10.
14. Ibid., 161.
15. IOM, Vaccine Supply and Innovation (Washington: National Academies Press, 1985).
16. IOM, Calling the Shots.
17. IOM, Financing Vaccines in the Twenty-first Century.
18. Mercer Management Consulting, Lessons Learned: New Procurement Strategies for Vaccines, Final Report to the GAVI Board, 28 June 2002, www.gaviftf.org/docs_activities/pdf/lessons_learned_draft_final.pdf (12 July 2004).
19. IOM, Risk Communication and Vaccination: Workshop Summary (Washington: National Academies Press, 1997); and A. Bostrom, "Vaccine Risk Communication: Lessons from Risk Perception, Decision Making and Environmental Risk Communication Research, 1997," www.fplc.edu/RISK/vol8/Spring/Bostrom. htm (12 July 2004).
20. IOM, Risk Communication and Vaccination: Workshop Summary (Washington: National Academies Press, 1997); and A. Bostrom, "Vaccine Risk Communication: Lessons from Risk Perception, Decision Making and Environmental Risk Communication Research, 1997," www.fplc.edu/RISK/vol8/Spring/Bostrom. htm (12 July 2004).
21. IOM, Vaccines for the Twenty-first Century: A Tool for Decisionmaking (Washington: National Academies Press, 2000).
22. C. Feudtner and E.K. Marcuse, "Ethics and Immunization Policy: Promoting Dialogue to Sustain Consensus," Pediatrics 107, no. 5 (2001): 1158-1164.
23. IOM, Evaluation of Poliomyelitis Vaccines (Washington: National Academies Press, 1977); and IOM, An Evaluation of Poliomyelitis Vaccine Policy Options (Washington: National Academies Press, 1988).
24. IOM, Evaluation of Poliomyelitis Vaccines (Washington: National Academies Press, 1977); and IOM, An Evaluation of Poliomyelitis Vaccine Policy Options (Washington: National Academies Press, 1988).
25. A.B. Hill, "The Environment and Disease: Association or Causation?" Proceedings of the Royal Society of Medicine 58 (1965): 295-300.
26. B.G. Gellin et al., "Do Parents Understand Immunizations? A National Telephone Survey," Pediatrics 106, no. 5 (2000): 1097-1102.
27. Activist organizations include Sensible Action for Ending Mercury-Induced Neurological Disorders (SAFEMINDS), www.safeminds.org, and the National Vaccine Information Center, www.909shot.com. Web sites and Internet discussion groups include the National Autism Association (NAA), at www.nationalautismassociation. org/index.php, and a Yahoo! group, Autism-Mercury, at health.groups.yahoo.com/ group/Autism-Mercury.
28. Examples include Parents of Kids with Infectious Diseases (PKIDS), at www.pkids.org/index2.htm, and the National Partnership for Immunization (NPI), at www.partnersforimmunization.org.
29. IOM, Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (Washington: National Academies Press, 2002).
30. IOM, Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders (Washington: National Academies Press, 2001); and IOM, Immunization Safety Review: Multiple Immunizations and Immune Dysfunction (Washington: National Academies Press, 2002).
31. IOM, Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders (Washington: National Academies Press, 2001); and IOM, Immunization Safety Review: Multiple Immunizations and Immune Dysfunction (Washington: National Academies Press, 2002).